Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in Human Immunodeficiency Virus (HIV-1) Infected, Antiretroviral Treatment-Naive Adults

ClinicalTrials.gov ID: NCT02607956

Public ClinicalTrials.gov record NCT02607956. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 1:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of GS-9883/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This primary objective of this study is to evaluate the efficacy of a fixed dose combination (FDC) containing bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) versus dolutegravir (DTG) + a FDC containing emtricitabine/tenofovir alafenamide (F/TAF) in HIV-1 infected, antiretroviral treatment-naive adults.

Study identification

NCT ID
NCT02607956
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gilead Sciences
Industry
Enrollment
657 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 11, 2015 (Actual)
Primary completion
May 12, 2017 (Actual)
Completion
Jul 5, 2021 (Actual)
Last update posted
Mar 7, 2022

2015 – 2021

United States locations

U.S. sites
74
U.S. states
21
U.S. cities
56
Facility City State ZIP Site status
Not listed Phoenix Arizona 85012 —
Not listed Phoenix Arizona 85025 —
Not listed Beverly Hills California 90211 —
Not listed Los Angeles California 90027 —
Not listed Los Angeles California 90036 —
Not listed Los Angeles California 90059 —
Not listed Los Angeles California 90069 —
Not listed Sacramento California 95817 —
Not listed Sacramento California 95825 —
Optimus Medical - ClinEdge - PPDS San Francisco California 94102 —
Kaiser Permanente San Leandro California 94577 —
Not listed Denver Colorado 80205 —
Not listed Washington D.C. District of Columbia 20009 —
Not listed Washington D.C. District of Columbia 20036 —
Not listed Washington D.C. District of Columbia 20037 —
Not listed DeLand Florida 32720 —
Not listed Fort Lauderdale Florida 33316 —
Not listed Ft. Pierce Florida 34982 —
Not listed Miami Florida 33133 —
Not listed Miami Florida 33136 —
Not listed Miami Beach Florida 33139 —
Not listed Oakland Park Florida 33306 —
Not listed Orlando Florida 32803 —
Not listed Pensacola Florida 32504 —
Not listed Tampa Florida 33614 —
Not listed West Palm Beach Florida 33407 —
Not listed Atlanta Georgia 30308 —
Not listed Atlanta Georgia 30312 —
Not listed Decatur Georgia 30033 —
Not listed Macon Georgia 31201 —
Not listed Savannah Georgia 31405 —
Not listed Chicago Illinois 60613 —
Not listed Chicago Illinois 60657 —
Not listed Indianapolis Indiana 46202 —
Sinai Hospital of Baltimore Baltimore Maryland 21215 —
Not listed Boston Massachusetts 02129 —
Not listed Boston Massachusetts 02215 —
Not listed Springfield Massachusetts 01105 —
Not listed Berkley Michigan 48072 —
Not listed Detroit Michigan 48202 —
Not listed Kansas City Missouri 64111 —
Not listed St Louis Missouri 63108 —
Not listed St Louis Missouri 63139 —
Not listed Hillsborough New Jersey 08844 —
Not listed Newark New Jersey 07102 —
Not listed Albany New York 12208 —
Not listed Manhasset New York 11030 —
Not listed New York New York 10011-4121 —
Not listed New York New York 10011 —
Not listed The Bronx New York 10461 —
Not listed Chapel Hill North Carolina 27514 —
Not listed Charlotte North Carolina 28207 —
Cone Health Regional Center for Infectious Disease Greensboro North Carolina 27401 —
Not listed Greenville North Carolina 27858-4354 —
Not listed Huntersville North Carolina 28078 —
Not listed Winston-Salem North Carolina 27157 —
Not listed Cincinnati Ohio 45267 —
Not listed Philadelphia Pennsylvania 19104 —
Not listed Philadelphia Pennsylvania 19107 —
Allegheny Health Network Pittsburgh Pennsylvania 15212 —
Not listed Columbia South Carolina 29203-6840 —
Not listed Austin Texas 78705 —
Not listed Bellaire Texas 77401 —
Not listed Dallas Texas 75202 —
AIDS Arms Inc Dallas Texas 75215 —
Not listed Dallas Texas 75235 —
North Texas Infectious Diseases Consultants PA Dallas Texas 75246 —
Not listed Fort Worth Texas 76104 —
Not listed Houston Texas 77004 —
Not listed Houston Texas 77098 —
Not listed Longview Texas 75605 —
Not listed Annandale Virginia 22003-7313 —
Not listed Seattle Washington 98104 —
Not listed Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02607956, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 7, 2022 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02607956 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →